KRAS and non-small cell lung carcinoma: Many studies have investigated molecular alterations in single genes in early-stage NSCLC and their prognostic and predictive implications [37], such as mutations in KRAS, P53, EGFR [38], STK11 [39], mRNA, and protein expression of ERCC1 [40,41].